Biotech Stocks Are Not For The Faint-Hearted
The biotech sector is soaring this year with the benchmark NYSE Arca Biotechnology Index up by over 27% YTD as of the end of September. Investors’ attraction towards biotech stocks shows no signs of showing as evidenced by many successful IPOs being launched on a weekly basis and also trading volumes. In addition, one of the top viewed pages …
Continue reading ‘Biotech Stocks Are Not For The Faint-Hearted’ »